Theranostics Health is a leading provider of proteomic services whose resources and capabilities offer unique opportunities for pursuing protein-based biomarker discovery or translational research strategies.
Preclinical Biomarker Discovery
- Target and Lead Discovery
- Target and Model Validation
- Assessment of Late-stage Preclinical Candidates
Translational Research
- Early Proof-of-Concept in Clinical Trials
- Surrogate Marker Development
- Patient Stratification Strategies
Proteomic Technologies
- Reverse-phase Protein Microarrays
- Laser Capture Microdissection
- TheraLin™ Fixatives
- Immunohistochemistry and Pathology Services